Pinnacle West Capital outperforms; least liked by analysts

CTT Pharmaceutical Holdings

29/08/2022 18:06

** Shares of Pinnacle West Capital Corp  PNW.N  rising 0.5% on
Mon, adding to gains it has made in 2022 despite being the least
favored S&P 500  .SPX  stock covered by sell-side analysts
    ** The electric utility co now up ~8% YTD vs S&P 500's
 .SPX  15% decrease
    ** Co sells electricity in Western United States and
operates Palo Verde nuclear power plant
    ** 10 analysts recommend selling PNW, two recommend buying
and four have neutral ratings, per Refinitiv
    ** Averaging out those recommendations, with 1 equating to a
'strong buy', 3 equating to 'hold' and 5 equating to a 'strong
sell', PNW currently ranks 3.5, at the bottom of the list of all
S&P 500 stocks. That avg rating has become slightly more
negative from 3.2 at the start of the year
    
    ** Its median PT is $69.0, which is 9.6% below its current
price of $76.33
    ** PNW currently pays a dividend yield of 4.48%, per
Refinitiv

    <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Pinnacle West Capital    https://tmsnrt.rs/3R0MgTQ
    ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
 (Reporting by Noel Randewich)
 ((noel.randewich@tr.com; Twitter: @randewich;))